News Many fixed dose drug combinations for sale in India are not approved BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2517 (Published 13 May 2015) Cite this as: BMJ 2015;350:h2517 Article Related content Metrics Responses Peer review Related articles News India signals crackdown on dubious fixed dose drug combinations Published: 17 July 2013; BMJ 347 doi:10.1136/bmj.f4588 See more Covid-19 exposes the high cost of India’s reliance on private healthcare BMJ September 10, 2020, 370 m3506; DOI: https://doi.org/10.1136/bmj.m3506 Covid-19: India should abandon lockdown and refocus its testing policy, say public health specialists BMJ September 02, 2020, 370 m3422; DOI: https://doi.org/10.1136/bmj.m3422 Breastfeeding in India is disrupted as mothers and babies are separated in the pandemic BMJ August 25, 2020, 370 m3316; DOI: https://doi.org/10.1136/bmj.m3316 Delhi prepares to hit 500 000 covid-19 cases BMJ July 14, 2020, 370 m2817; DOI: https://doi.org/10.1136/bmj.m2817 Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis BMJ May 29, 2020, 369 m2170; DOI: https://doi.org/10.1136/bmj.m2170
